ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002